The Medicrea Group reported audited group earnings results for the year ended December 31, 2017. For the year, the company’s sales were EUR 27.1 million compared to EUR 29.4 million a year ago. Operating loss before amortization and provision (LBITDA) was EUR 2.1 million compared to EBITDA of EUR 0.3 million a year ago. Operating loss before non-recurring expenses was EUR 7.6 million compared to EUR 4.5 million a year ago. Loss before tax was EUR 11.2 million compared to EUR 7.8 million a year ago. Net loss was EUR 10.7 million compared to EUR 7.6 million a year ago.